cyclerion.com (CYCN) - Bozor qiymatining balans qiymatiga nisbati
Cyclerion Therapeutics (CYCN) o'z patentlarini sog'liqni saqlash gigantlari bilan hamkorlik orqali monetizatsiya qilmoqda, bu esa bozor qiymatining buxgalteriya qiymatiga nisbati (market-to-book ratio) o'zgarishida aks etgan. 2.81 miya va buyrak tomirlari uchun dori vositalari portfelining ishlab chiqilishi jarayonida yangi darajani qayd etmoqda. Guanilat siklaza stimulyatorlarining ko'p bosqichli sinovlari barqarorlikni ta'minlab, yagona loyihaga bog'lanish bilan bog'liq xavflarni minimallashtiradi.
Cyclerion Therapeutics (CYCN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Cyclerion Therapeutics|CYCN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati cyclerion.com|CYCN - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Cyclerion|CYCN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli majburiyatlari Cyclerion Therapeutics|Tezkor likvidlik koeffitsiyenti cyclerion.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Cyclerion Therapeutics Inc. - CYCN
Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati bozorni emitentning sof aktivlari uchun qancha premium to'lashga tayyorligini belgilaydi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati grafigini tahlil qilish orqali investor kapitalga bo'lgan bozor ishonchi dinamikasini kuzatishi mumkin. Ushbu metrika aksiyaning joriy narxining kapitalga bo'linishi natijasida hisoblanadi. Cyclerion Therapeutics (CYCN) uchun ushbu koeffitsient robotlashtirilgan bioinformatika platformalarining intellektual mulk huquqlari qiymatini aks ettiradi. Bu yerdagi yuqori qiymatlar dori vositalarini kashf qilishni avtomatlashtirish samaradorligini tasdiqlaydi, bu esa jismoniy aktivlardan tashqari qo'shimcha qiymat yaratadi.
Asosiy raqobatchilar
Biogen Inc. (BIIB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati NBIX|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati trevitherapeutics.com (TRVI)|Kapitallashuvning sof aktivlarga nisbati PRAX (Praxis Precision Medicines, Inc.)|AVXL - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati CBLL (CeriBell Corp)|PRTA - Kapitallashuvning sof aktivlarga nisbati|ALEC - Bozor qiymatining balans qiymatiga nisbati|ANNX: Bozor qiymatining balans qiymatiga nisbati|OMER: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Neurogene Inc (NGNE)|Bozor qiymatining balans qiymatiga nisbati AC Immune Corp|VYGR: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati NMRA|Balans qiymatiga nisbatan bozor kapitallashuvi scilexholding.com|Bozor qiymatining balans qiymatiga nisbati Tevogen Bio TVGN|Alpha Cognition Inc (ACOG) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CGTX - Bozor qiymatining balans qiymatiga nisbati|IKT (Inhibikase Pharma) - Kapitallashuvning balans qiymatiga nisbati|SAVA (Cassava Sciences, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Assertio - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati COYA|VTGN (VistaGen Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati OVID|ABOS (Acumen Pharmaceuticals, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CRVO (CervoMed Inc.)|Alterity Therapeutics Ltd. (ATHE) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CLNN - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati PEPG (PepGen Inc.)|JUNS: Bozor kapitallashuvining balans qiymatiga nisbati|Relmada Corp (RLMD) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Annovis Bio, Inc.|Grace Tx - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati AIFF|KLTO - Bozor qiymatining balans qiymatiga koeffitsiyenti|NeuroSense Therapeutics Ltd. - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Reviva Pharmaceuticals, Inc. RVPH|MTVA: Kapitallashuvning sof aktivlarga nisbati|neuraxis.com - Bozor kapitallashuvining balans qiymatiga multiplikatori|HSDT: Bozor kapitallashuvining balans qiymatiga nisbati|PASG - Balans qiymatiga nisbatan bozor kapitallashuvi|NEUP (Neuphoria Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Minerva (NERV)|Bozor qiymatining balans qiymatiga nisbati Athira Pharma, Inc. (ATHA)|Balans qiymatiga nisbatan bozor kapitallashuvi addextherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati ALZN (Alzamend Neuro)|PTIX - Kapitallashuvning sof aktivlarga nisbati|KTTA: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cortigent, Inc.|ATXI: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati brainstorm-cell.com|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics|Kapitallashuvning balans qiymatiga nisbati CHRO (Chromocell Therapeutics Corp)|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics (ELYM)|intracellulartherapies.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati LBPH (Longboard Pharmaceuticals)|marinuspharma.com (MRNS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGN: Kapitallashuvning sof aktivlarga nisbati|NRBO - Bozor kapitallashuvining balans qiymatiga nisbati|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Synaptogenix, Inc - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro VIGL|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Kapitallashuvning sof aktivlarga nisbati Cerevel Therapeutics Inc CERE